Delivery Order SPE2DB22D3401-SPE2DB25FT6CW
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,732.25 for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, non-set-aside contract utilized firm fixed pricing and was completed on July 25, 2025, just one day after the award date of July 24, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which aligns with AmerisourceBergen's corporate headquarters location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,403.86 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard transactional award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $18,477.90 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of September 10, 2025, is performed at the contractor's location in Conshohocken, Pennsylvania. The award utilized competitive procedures with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- The Defense Logistics Agency awarded a delivery order valued at $3,152.10 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine procurement action supporting...
- The Defense Logistics Agency awarded a $165,523.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $123,186.00 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (a combination meningococcal vaccine) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,517.62 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 3, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product with a ceiling value of $3,659.10. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order is scheduled...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6CWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,197.92 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a competitively awarded non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, medications, and medical devices across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/11/25 |